Daily treatment with the antiviral drug tenofovir during the third trimester of pregnancy significantly reduced the risk of hepatitis B (HBV) transmission from mother to baby, according to new US research. The findings of the study could potentially help to eradicate the disease, say the researchers involved. The clinical trial was led by researchers from NYU Langone Medical Centre, who…
Read more > Antiviral drug reduced hepatitis B transmission risk in pregnancy
